Mecamylamine (a nicotine antagonist) for smoking cessation: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Mecamylamine (a Nicotine Antagonist) for Smoking Cessation: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438498/1/Interventions_for_chronic_kidney_disease_in_people_with_sickle_cell_disease_New. Accessed 29 March 2024.
Mecamylamine (a nicotine antagonist) for smoking cessation: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438498/1/Interventions_for_chronic_kidney_disease_in_people_with_sickle_cell_disease_New. Accessed March 29, 2024.
Mecamylamine (a nicotine antagonist) for smoking cessation: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438498/1/Interventions_for_chronic_kidney_disease_in_people_with_sickle_cell_disease_New
Mecamylamine (a Nicotine Antagonist) for Smoking Cessation: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438498/1/Interventions_for_chronic_kidney_disease_in_people_with_sickle_cell_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Mecamylamine (a nicotine antagonist) for smoking cessation: Cochrane systematic review
ID - 438498
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438498/1/Interventions_for_chronic_kidney_disease_in_people_with_sickle_cell_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -